Advertisement

Ads Placeholder
Loading...

Atai Beckley N.V

ATAI•NASDAQ
Healthcare
Medical - Pharmaceuticals
$3.79
$0.09(2.43%)
U.S. Market opens in NaNh NaNm

Atai Beckley N.V (ATAI) Stock Overview

Explore Atai Beckley N.V’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap714.9M
P/E Ratio-1.80
EPS (TTM)$-0.83
ROE-3.90%
Fundamental Analysis

AI Price Forecasts

1 Month$3.53
3 Months$3.09
1 Year Target$6.37

ATAI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Atai Beckley N.V (ATAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.80 and a market capitalization of 714.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.43%
5-Day Change
4.70%
1-Month Change
2.71%
3-Month Change
-2.07%
6-Month Change
-27.53%
Year-to-Date (YTD) Change
-2.07%
1-Year Change
187.12%
3-Year Change
99.47%
5-Year Change
-80.95%
All-Time (Max) Change
-80.95%

Contact Information

https://www.ataibeckley.com
31 20 793 2536
Prof. J.H. Bavincklaan 7, Amstelveen, NaN, 1183 AT

Company Facts

540 Employees
IPO DateJun 18, 2021
CountryNL
Actively Trading

Frequently Asked Questions